<DOC>
	<DOCNO>NCT00879099</DOCNO>
	<brief_summary>The aim study investigate effect antidepressant paroxetine , plasma level timolol main metabolite topical application ophthalmic timolol product . This phase I , randomise , 4-phase cross-over study healthy volunteer . Healthy male volunteer age 18 - 40 year enrol . Placebo paroxetine give three day 1 drop timolol product administer eye . The duration paroxetine placebo treatment period 3 day . There four different treatment period . A washout study period least 4 week .</brief_summary>
	<brief_title>Interaction Study Timolol Eye Drops Paroxetine Capsules</brief_title>
	<detailed_description />
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>male 18 40 year age good general health willing follow instruction provide write informed consent BMI 18.5 26 systolic blood pressure least 105 mmHg haemoglobin least 135 g/l . know hypersensitivity timolol , paroxetine component study medication contraindication timolol treatment include asthma obstructive lung disease contraindication paroxetine treatment heart rate 50/min less rest regular medication allergy require antihistamine ocular nasal treatment clinically significant abnormality ( normal limit ) laboratory value : basic blood count , creatinine , ALAT , AFOS , gammaGT , K , Na clinically significant EKG abnormality assess investigator blood donation within last 60 day ( required time period two donation men give RedCross Finland ) . participation another clinical trial involve investigational drug/device , participation trial within last 60 day</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Interaction</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>Interaction study healthy volunteer</keyword>
</DOC>